Farzan brings more than two decades’ leadership experience with a strong track record in fundraising and IPOs THOUSAND OAKS, Calif., July 22, 2024 /PRNewswire/ — Latigo Biotherapeutics Inc. (“Latigo”), a clinical-stage biotechnology company developing best-in-class non-opioid pain…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.